Atlas Trials

Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction

Clinical trial NCT02709343 · COMPLETED

Trial details

NCT number
NCT02709343
Sponsor
The University of Queensland
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lung Allograft Dysfunction (CLAD)
Start date
2017-04-21
Primary completion
2023-09-13
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.